<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Pediatr Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J Pediatr Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">JPN</journal-id>
<journal-title-group>
<journal-title>Journal of Pediatric Neurosciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1817-1745</issn>
<issn pub-type="epub">1998-3948</issn>
<publisher>
<publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30271470</article-id>
<article-id pub-id-type="pmc">6144599</article-id>
<article-id pub-id-type="publisher-id">JPN-13-340</article-id>
<article-id pub-id-type="doi">10.4103/JPN.JPN_178_17</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Rare Cause of Refractory Epilepsy: Posterior Periventricular Nodular Heterotopia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Direk</surname>
<given-names>Meltem C.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Komur</surname>
<given-names>Mustafa</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ozgur</surname>
<given-names>Anıl</given-names>
</name>
<xref ref-type="aff" rid="aff2">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Okuyaz</surname>
<given-names>Cetin</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
</contrib-group>
<aff id="aff1">Division of Pediatric Neurology, Department of Pediatrics University of Mersin School of Medicine, Mersin, Turkey</aff>
<aff id="aff2"><label>1</label>Department of Radiology, University of Mersin School of Medicine, Mersin, Turkey</aff>
<author-notes>
<corresp id="cor1"><bold><italic>Address for correspondence: </italic></bold> Dr. Meltem Cobanogullari Direk, Division of Pediatric Neurology, Department of Pediatrics, University of Mersin School of Medicine, 34 Cadde, Ciftlikkoy Kampusu 33343, Mersin, Turkey. E-mail: <email xlink:href="m_lt_m82@hotmail.com">m_lt_m82@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Jul-Sep</season>
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<fpage>340</fpage>
<lpage>342</lpage>
<permissions>
<copyright-statement>Copyright: © 2018 Journal of Pediatric Neurosciences</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0">
<license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p>
</license>
</permissions>
<abstract>
<p>A 15-year-old male patient presented to our outpatient clinic with drug-resistant seizures. Magnetic resonance imaging of the brain showed bilateral posterior nodular heterotopia and left cerebellar dysgenesis. The patient was diagnosed with cortical developmental malformation and medically refractory epilepsy. The filamin A gene mutation was negative. Posterior periventricular nodular heterotopia is a rarer and a more different entity from classical periventricular nodular heterotopia with no gender difference and negative filamin A gene mutation. There is a limited number of case studies on posterior periventricular heterotopia. Therefore, this patient was presented to emphasize that epilepsy may be more refractory to treatment, and central congenital abnormalities including posterior fossa abnormalities are more frequent in patients with posterior periventricular nodular heterotopia.</p>
</abstract>
<kwd-group>
<title>K<sc>EYWORDS</sc>:</title>
<kwd>
<italic>Cerebellar dysgenesis</italic>
</kwd>
<kwd>
<italic>posterior periventricular nodular heterotopia</italic>
</kwd>
<kwd>
<italic>refractory epilepsy</italic>
</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>I<sc>NTRODUCTION</sc></title>
<p>Heterotopia is defined as clustering of the normal neurons in abnormal locations as a result of interruption of the radial migration from periventricular germinal layer to the cortical layer during intrauterine period. It has been classified into three subgroups as subependymal, focal subcortical, and band heterotopia, according to the site of abnormal location. These subtypes of heterotopia can represent various clinical signs including seizures (Lennox–Gastaut syndrome, infantile spasms, etc.), mental and motor retardation, dysarthria, tetraplegia, and hemiplegia. Diagnosis is made by magnetic resonance imaging (MRI) studies by observing a signal characteristic to cortex in the white matter on all sequences.</p>
<p>Periventricular nodular heterotopia (PNH) is characterized by subependymal location of heterotopic gray matter in the walls of ventricles. Frontocentral region is the most common site of location.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref2">2</xref>] <italic>FLNA</italic> gene mutation is found in all cases of PNH and in 20% of sporadic cases. Recently, a subgroup of heterotopia has been defined in a few patients with a negative <italic>FLNA</italic> mutation and posteriorly located heterotopia.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref4">4</xref><xref ref-type="bibr" rid="ref5">5</xref>] This paper presents a patient representing refractory epilepsy in which posterior PNH was diagnosed in brain MRI as a rare cause of refractory epilepsy of childhood.</p>
</sec>
<sec id="sec1-2">
<title>C<sc>ASE</sc> R<sc>EPORT</sc></title>
<p>A 15-year-old male patient referred to our outpatient clinic with refractory epilepsy. Medical history revealed complex partial seizures that first began at 1.5 years of age, which was treated with carbamazepine for 2.5 years. As seizures stopped, the drug was ceased gradually, resulting in no more seizures for 3 years. Although carbamazepine was restarted 3 years later because of recurrence of seizures, the patient had seizures 3–4 times in a month and even several times during a day on some days.</p>
<p>The parents reported that he was born in hospital by spontaneous vaginal birth, he had no prenatal and postnatal health problems, he is successful in the school and he also had a healthy brother. And the parents had no consanguineous relationship.</p>
<p>On physical examination, neuromotor development was found to be appropriate for his age. Neurological examination revealed no pathological findings. Complete blood count and biochemical tests revealed normal findings. On the other hand, electroencephalography showed slow spike and wave complexes arising from the posterior regions of the right hemisphere. Cerebral MRI obtained to determine the etiology of seizures revealed left cerebellar dysgenesis and bilateral peritrigonal and temporo-occipital heterotropia (suggestive of posterior PNH) [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Because of ongoing epileptic seizures, levetiracetam (40 mg/kg/day) and zonisamide (5 mg/kg/day) were added to carbamazepine (30 mg/kg/day) treatment, respectively. <italic>FLNA</italic> gene mutation was found to be negative. The patient was asked to follow- up every 3 months at outpatient clinic, and he reported no more seizures for the last 2 years.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>(A) Coronal T2-W. (B) Coronal FLAIR. (C) Axial T2-W. (D) Axial FLAIR. Bilateral periventricular nodular heterotopia at the peritrigonal and temporo-occipital location</p>
</caption>
<graphic xlink:href="JPN-13-340-g001"></graphic>
</fig>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>D<sc>ISCUSSION</sc></title>
<p>PNH is a rare disorder of cortical development. And it is the most common gray matter heterotopia seen in clinical practice. Classical bilateral PNH is an X-chromosome-related neurodevelopmental disorder, which is characterized by bilateral symmetrical subependymal nodules on brain MRI. It often results from filamin A gene (<italic>FLN1</italic>, locus Xq28) mutations. The neuronal migration abnormalities caused by these mutations are particularly seen in girls. Clinical picture varies from normal cognitive functions to severe mental retardation and from asymptomatic individuals to refractory epileptic seizures.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref2">2</xref>]</p>
<p>Posterior PNH is a rarer and a more different entity than the classical PNH with no gender difference and negative <italic>FLNA</italic> mutation. In a limited number of case studies on posterior periventricular heterotopia, it has been seen that the disease is associated with refractory epilepsy and increased incidence of brain abnormalities compared to the classical PNH.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref4">4</xref><xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref>]</p>
<p>In their study on 50 patients with PNH, Pisano <italic>et al</italic>.[<xref ref-type="bibr" rid="ref6">6</xref>] identified treatment-resistant epilepsy in 62%, cognitive disorders in 56%, autism in 12%, and cerebellar abnormality on brain MRI in 56% of the patients. The authors suggested that any type of seizures can be seen in these patients, with treatment-resistant complicated partial seizures being the most common.[<xref ref-type="bibr" rid="ref6">6</xref>] Our patient had treatment-resistant complex partial seizures that could be controlled with triple antiepileptic drugs.</p>
<p>When compared to the patients with mutation-positive PNH, the patients with <italic>FLNA</italic>-negative PNH more commonly have other brain abnormalities (hydrocephalus, microcephaly, frontonasal dysplasia, etc.), and they are known as being a part of infrasylvian developmental disorder.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref>] Mandelstam <italic>et al</italic>.[<xref ref-type="bibr" rid="ref3">3</xref>] studied the cerebral abnormalities associated with bilateral posterior PNH and found that most commonly associated disorders are corpus callosum dysgenesis, colpocephaly, cortical abnormalities, hippocampal abnormalities, and infrasylvian developmental disorders. Accordingly, our patient had left cerebellar dysgenesis associated with posterior PNH. <italic>FLNA</italic> mutation-negative posterior PNH is concluded to be a subtype of classical PNH or caused by a currently undetected abnormality on <italic>FLNA</italic> gene. The patient presented in this paper was also negative for <italic>FLNA</italic> mutation.</p>
</sec>
<sec id="sec1-4" sec-type="conclusion">
<title>C<sc>ONCLUSION</sc></title>
<p>Posterior PNH is a cortical developmental abnormality, which is not only characterized by the location of nodules but also associated with refractory seizures and brain abnormalities with no <italic>FLNA</italic> gene mutations.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref><xref ref-type="bibr" rid="ref8">8</xref>] A limited number of cases of posterior PNH and accompanying abnormalities have been reported.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref><xref ref-type="bibr" rid="ref8">8</xref>] Therefore, it was aimed to emphasize that epilepsy may be more refractory to treatment, and central congenital abnormalities including posterior fossa abnormalities are more frequent in patients with posterior PNH, which should be considered when etiology of epilepsy is investigated in this group of patients.</p>
<sec id="sec2-1">
<title>Financial support and sponsorship</title>
<p>Nil.</p>
</sec>
<sec id="sec2-2" sec-type="COI-statement">
<title>Conflicts of interest</title>
<p>There are no conflicts of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>R<sc>EFERENCES</sc></title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battaglia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chiapparini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Franceschetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Freri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tassi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bassanini</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Periventricular nodular heterotopia: classification, epileptic history, and genesis of epileptic discharges</article-title>
<source/>Epilepsia
          <year>2006</year>
<volume>47</volume>
<fpage>86</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="pmid">16417536</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ramazzotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Veggiotti</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Periventricular heterotopia: phenotypic heterogeneity and correlation with filamin A mutations</article-title>
<source/>Brain
          <year>2006</year>
<volume>129</volume>
<fpage>1892</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="pmid">16684786</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandelstam</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Leventer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Sandow</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McGillivray</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van Kogelenberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bilateral posterior periventricular nodular heterotopia: a recognizable cortical malformation with a spectrum of associated brain abnormalities</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2013</year>
<volume>34</volume>
<fpage>432</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">23348762</pub-id>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovac</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Micallef</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Diehl</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Mystery case: bilateral posterior periventricular heterotopias</article-title>
<source/>Neurology
          <year>2013</year>
<volume>81</volume>
<fpage>e163</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">24276339</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guglielmi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Floris</surname>
<given-names>R</given-names>
</name>
<name>
<surname>D’Adamo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garaci</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sbraccia</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Massive obesity and hyperphagia in posterior bilateral periventricular heterotopias: case report</article-title>
<source/>BMC Med Genet
          <year>2016</year>
<volume>17</volume>
<fpage>18</fpage>
<pub-id pub-id-type="pmid">26956990</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pisano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Leventer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Squier</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Parrini</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Peritrigonal and temporo-occipital heterotopia with corpus callosum and cerebellar dysgenesis</article-title>
<source/>Neurology
          <year>2012</year>
<volume>79</volume>
<fpage>1244</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">22914838</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>González</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vedolin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Poduri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Location of periventricular nodular heterotopia is related to the malformation phenotype on MRI</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2013</year>
<volume>34</volume>
<fpage>877</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">23064591</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>An</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Sporadic periventricular nodular heterotopia: classification, phenotype and correlation with filamin A mutations</article-title>
<source/>Epilepsy Res
          <year>2017</year>
<volume>133</volume>
<fpage>33</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">28411558</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>